BNP/CALL/NOVO-NORDISK B/600/0.1/20.09.24 Stock

Warrant

DE000PC1F3L3

Market Closed - Boerse Frankfurt Warrants 10:21:04 2024-06-28 EDT
5.55 EUR +1.83% Intraday chart for BNP/CALL/NOVO-NORDISK B/600/0.1/20.09.24
Current month+23.88%
1 month+29.07%
Date Price Change
24-06-28 5.55 +1.83%
24-06-27 5.45 -2.50%
24-06-26 5.59 -1.58%
24-06-25 5.68 +7.98%
24-06-24 5.26 0.00%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 10:21 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1F3L
ISINDE000PC1F3L3
Date issued 2023-12-08
Strike 600 kr
Maturity 2024-09-20 (82 Days)
Parity 10 : 1
Emission price 1.76
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.74
Lowest since issue 1.47
Delta0x
Omega 0.000000
Premium0x
Gearing2.45x
Moneyness 1.676
Difference Strike -405.6 kr
Difference Strike %-67.60%
Spread 0.04
Spread %0.72%
Intrinsic value 5.434
Present value 0.0762

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006 DKK
Average target price
949.7 DKK
Spread / Average Target
-5.56%
Consensus